| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8786673 | European Journal of Surgical Oncology (EJSO) | 2018 | 8 Pages |
Abstract
The HRQOL in patients with colorectal peritoneal metastases undergoing CRSÂ +Â IPC appear similar to those receiving systemic chemotherapy. Two-year survivors in the CRSÂ +Â IPC arm have comparable HRQOL to a general population reference. The treatment is cost-effective according to NICE guidelines.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
P.H. Cashin, H. Mahteme, I. Syk, J.E. Frödin, B. Glimelius, W. Graf,